|
1
|
Seidman MD, Gurgel RK, Lin SY, Schwartz
SR, Baroody FM, Bonner JR, Dawson DE, Dykewicz MS, Hackell JM, Han
JK, et al: Guideline otolaryngology development group. AAO-HNSF.
Clinical practice guideline: Allergic rhinitis. Otolaryngol Head
Neck Surg. 152 (Suppl 1):S1–S43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bachert C, Wagenmann M and Holtappels G:
Cytokines and adhesion molecules in allergic rhinitis. Am J Rhinol.
12:3–8. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang DY and Clement P: Pathogenic
mechanisms underlying the clinical symptoms of allergic rhinitis.
Am J Rhinol. 14:325–333. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pawankar R, Mori S, Ozu C and Kimura S:
Overview on the pathomechanisms of allergic rhinitis. Asia Pac
Allergy. 1:157–167. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cavagnero K and Doherty TA: Cytokine and
lipid mediator regulation of group 2 innate lymphoid cells (ILC2s)
in human allergic airway disease. J Cytokine Biol. 2(pii):
1162017.PubMed/NCBI
|
|
6
|
Björkström NK, Kekäläinen E and Mjösberg
J: Tissue-specific effector functions of innate lymphoid cells.
Immunology. 139:416–427. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spits H, Artis D, Colonna M, Diefenbach A,
Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius
RE, et al: Innate lymphoid cells-a proposal for uniform
nomenclature. Nat Rev Immunol. 13:145–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartemes KR, Kephart GM, Fox SJ and Kita
H: Enhanced innate type 2 immune response in peripheral blood from
patients with asthma. J Allergy Clin Immunol. 134:671–678.e4. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Doherty TA, Scott D, Walford HH, Khorram
N, Lund S, Baum R, Chang J, Rosenthal P, Beppu A, Miller M and
Broide DH: Allergen challenge in allergic rhinitis rapidly induces
increased peripheral blood type 2 innate lymphoid cells that
express CD84. J Allergy Clin Immunol. 133:1203–1205. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fan D, Wang X, Wang M, Wang Y, Zhang L, Li
Y, Fan E, Cao F, Van Crombruggen K, Zhang L, et al:
Allergen-dependent differences in ILC2s frequencies in patients
with allergic rhinitis. Allergy Asthma Immunol Res. 8:216–222.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bousquet J, Schünemann HJ, Samolinski B,
Demoly P, Baena-Cagnani CE, Bachert C, Bonini S, Boulet LP,
Bousquet PJ, Brozek JL, et al: Allergic rhinitis and its impact on
asthma (ARIA): Achievements in 10 years and future needs. J Allergy
Clin Immunol. 130:1049–1062. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bousquet J, Bachert C, Canonica GW, Mullol
J, Van Cauwenberge P, Bindslev Jensen C, Fokkens WJ, Ring J, Keith
P, Lorber R, et al: Efficacy of desloratadine in intermittent
allergic rhinitis: A GA (2)LEN study. Allergy. 64:1516–1523. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pilette C, Jacobson MR, Ratajczak C, Detry
B, Banfield G, VanSnick J, Durham SR and Nouri-Aria KT: Aberrant
dendritic cell function conditions Th2-cell polarization in
allergic rhinitis. Allergy. 68:312–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Skrindo I, Ballke C, Gran E, Johansen FE,
Baekkevold ES and Jahnsen FL: IL-5 production by resident mucosal
allergen-specific T cells in an explant model of allergic rhinitis.
Clin Exp Allergy. 45:1296–1304. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lao-Araya M, Steveling E, Scadding GW,
Durham SR and Shamji MH: Seasonal increases in peripheral innate
lymphoid type 2 cells are inhibited by subcutaneous grass pollen
immunotherapy. J Allergy Clin Immunol. 134:1193–1195.e4. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhong H, Fan XL, Yu QN, Qin ZL, Chen D, Xu
R, Chen DH, Lin ZB, Wen W and Fu QL: Increased innate type 2 immune
response in house dust mite-allergic patients with allergic
rhinitis. Clin Immunol. 183:293–299. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Christianson CA, Goplen NP, Zafar I, Irvin
C, Good JT Jr, Rollins DR, Gorentla B, Liu W, Gorska MM, Chu H, et
al: Persistence of asthma requires multiple feedback circuits
involving type 2 innate lymphoid cells and IL-33. J Allergy Clin
Immunol. 136:59–68.e14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagakumar P, Denney L, Fleming L, Bush A,
Lloyd CM and Saglani S: type 2 innate lymphoid cells in induced
sputum from children with severe asthma. J Allergy Clin Immunol.
137:624–626.e6. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mjösberg JM, Trifari S, Crellin NK, Peters
CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T and Spits H: Human
IL-25- and IL-33-responsive type 2 innate lymphoid cells are
defined by expression of CRTH2 and CD161. Nat Immunol.
12:1055–1062. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Walford HH, Lund SJ, Baum RE, White AA,
Bergeron CM, Husseman J, Bethel KJ, Scott DR, Khorram N, Miller M,
et al: Increased ILC2s in the eosinophilic nasal polyp endotype are
associated with corticosteroid responsiveness. Clin Immunol.
155:126–135. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miljkovic D, Bassiouni A, Cooksley C, Ou
J, Hauben E, Wormald PJ and Vreugde S: Association between group 2
innate lymphoid cells enrichment, nasal polyps and allergy in
chronic rhinosinusitis. Allergy. 69:1154–1161. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ho J, Bailey M, Zaunders J, Mrad N, Sacks
R, Sewell W and Harvey RJ: Group 2 innate lymphoid cells (ILC2s)
are increased in chronic rhinosinusitis with nasal polyps or
eosinophilia. Clin Exp Allergy. 45:394–403. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eastman JJ, Cavagnero KJ, Deconde AS, Kim
AS, Karta MR, Broide DH, Zuraw BL, White AA, Christiansen SC,
Doherty TA, et al: Group 2 innate lymphoid cells are recruited to
the nasal mucosa in patients with aspirin-exacerbated respiratory
disease. J Allergy Clin Immunol. 140:101–108.e3. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Doherty TA: At the bench: Understanding
group 2 innate lymphoid cells in disease. J Leukoc Biol.
97:455–467. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Johansson K, Malmhäll C, Ramos-Ramírez P
and Rådinger M: Bone marrow type 2 innate lymphoid cells: A local
source of interleukin-5 in interleukin-33-driven eosinophilia.
Immunology. 153:268–278. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xue L, Salimi M, Panse I, Mjösberg JM,
McKenzie AN, Spits H, Klenerman P and Ogg G: Prostaglandin D2
activates group 2 innate lymphoid cells through chemoattractant
receptor-homologous molecule expressed on TH2 cells. J Allergy Clin
Immunol. 133:1184–1194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Salimi M, Stöger L, Liu W, Go S, Pavord I,
Klenerman P, Ogg G and Xue L: Cysteinyl leukotriene E4
activates human group 2 innate lymphoid cells and enhances the
effect of prostaglandin D2 and epithelial cytokines. J
Allergy Clin Immunol. 140:1090–1100.e11. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Doherty TA, Khorram N, Lund S, Mehta AK,
Croft M and Broide DH: Lung type 2 innate lymphoid cells express
cysteinyl leukotriene receptor 1, which regulates TH2 cytokine
production. J Allergy Clin Immunol. 132:205–213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miao Q, Wang Y, Liu YG, Ren YX, Guan H, Li
Z, Xu W and Xiang L: Seasonal variation in circulating group 2
innate lymphoid cells in mugwort-allergic asthmatics during and
outside pollen season. Allergy Asthma Clin Immunol. 14:62018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang XY, Ma TT, Wang XY, Zhuang Y, Wang
XD, Ning HY, Shi HY, Yu RL, Yan D, Huang HD, et al: Prevalence of
pollen-induced allergic rhinitis with high pollen exposure in
grasslands of northern China. Allergy. 73:1232–1243. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen K, Liao YF and Zhang JT: The major
aeroallergens in Guangxi, China. Clin Allergy. 18:589–596. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jahn-Schmid B, Kelemen P, Himly M, Bohle
B, Fischer G, Ferreira F and Ebner C: The T cell response to Art v
1, the major mugwort pollen allergen, is dominated by one epitope.
J Immunol. 169:6005–6011. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fu W, Gao Z, Gao L, Jin J, Liu M, Sun Y,
Wu S, Wu L, Ma H, Dong Y, et al: Identification of a 62-kDa major
allergen from Artemisia pollen as a putative galactose oxidase.
Allergy. 73:1041–1052. 2017. View Article : Google Scholar
|
|
34
|
Wopfner N, Gadermaier G, Egger M, Asero R,
Ebner C, Jahn-Schmid B and Ferreira F: The spectrum of allergens in
ragweed and mugwort pollen. Int Arch Allergy Immunol. 138:337–346.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu CK and Chen CL: Activation of mast
cells is essential for development of house dust mite
Dermatophagoides farinae-induced allergic airway inflammation in
mice. J Immunol. 171:3808–3815. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chu DK, Llop-Guevara A, Walker TD, Flader
K, Goncharova S, Boudreau JE, Moore CL, Seunghyun In T, Waserman S,
Coyle AJ, et al: IL-33, but not thymic stromal lymphopoietin or
IL-25, is central to mite and peanut allergic sensitization. J
Allega Clin Immunol. 131:187–200.e1-8. 2013. View Article : Google Scholar
|
|
37
|
Jia Y, Fang X, Zhu X, Bai C, Zhu L, Jin M,
Wang X, Hu M, Tang R and Chen Z: IL-13+ type 2 innate lymphoid
cells correlate with asthma control status and treatment response.
Am J Respir Cell Mol Biol. 55:675–683. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang H, Lin J, Zeng L, Ouyang C, Ran P,
Yang P and Liu Z: Der f 31, a novel allergen from Dermatophagoides
farinae, activates epithelial cells and enhances lung-resident
group 2 innate lymphoid cells. Sci Rep. 7:85192017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Smith SG, Chen R, Kjarsgaard M, Huang C,
Oliveria JP, O'Byrne PM, Gauvreau GM, Boulet LP, Lemiere C, Martin
J, et al: Increased numbers of activated group 2 innate lymphoid
cells in the airways of patients with severe asthma and persistent
airway eosinophilia. J Allergy Clin Immunol. 137:75–86.e8. 2016.
View Article : Google Scholar : PubMed/NCBI
|
